Markus Weiler

28PUBLICATIONS
151CO-AUTHORS
Peripheral nervous systemGene and molecular therapyPanel data analysisAutonomic nervous systemNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Sep 04, 2026
Impact of Baseline Polyneuropathy Severity on Eplontersen Efficacy in the NEURO-TTRansform Clinical Trial.

|Aug 12, 2026
Disease modifying treatment of hereditary transthyretin amyloidosis with polyneuropathy in Germany - expert consensus of the German society of amyloid diseases (DGAK) and the German neurological society (DGN).

|Jul 09, 2026
Guidelines for the management of hereditary ATTR amyloidosis 2026.

|Jun 10, 2026
First-Generation TTR Silencing Therapies in Hereditary Transthyretin Amyloidosis With Polyneuropathy: Real-World Insights From a German Single-Referral Center.

|Apr 06, 2026
Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy: An Exploratory Analysis of Treatment Effect in Male and Female Patients.

Márcia Waddington Cruz, John L Berk, Yeşim Parman

|Mar 31, 2026
Effect of Eplontersen in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy Across Genetic Variants: An Exploratory Analysis From the NEURO-TTRansform Trial.

Julian D Gillmore, David Adams, Markus Weiler

Pageof 5

Frequent Collaborators

7 joint publications

Jennifer Kollmer

4 joint publications

Wolfgang Wick

4 joint publications

Ute Hegenbart

4 joint publications

Stefan Schönland